Published in Biochem Biophys Res Commun on June 27, 2003
Enhanced proliferation of cultured human vascular smooth muscle cells linked to increased function of RNA-binding protein HuR. J Biol Chem (2005) 1.12
Mutations in SCARF2 are responsible for Van Den Ende-Gupta syndrome. Am J Hum Genet (2010) 1.06
Oxidized low-density lipoproteins upregulate proline oxidase to initiate ROS-dependent autophagy. Carcinogenesis (2009) 1.00
Multipotent human stromal cells improve cardiac function after myocardial infarction in mice without long-term engraftment. Biochem Biophys Res Commun (2007) 2.35
Muscle-specific expression of IGF-1 blocks angiotensin II-induced skeletal muscle wasting. J Clin Invest (2005) 2.24
Targeted ablation of IKK2 improves skeletal muscle strength, maintains mass, and promotes regeneration. J Clin Invest (2006) 2.13
IGF-1 reduces inflammatory responses, suppresses oxidative stress, and decreases atherosclerosis progression in ApoE-deficient mice. Arterioscler Thromb Vasc Biol (2007) 1.64
Effect of congestive heart failure on the insulin-like growth factor-1 system. Am J Cardiol (2002) 1.48
Is angiotensin II a direct mediator of left ventricular hypertrophy? Time for another look. Hypertension (2007) 1.22
A redox-sensitive pathway mediates oxidized LDL-induced downregulation of insulin-like growth factor-1 receptor. J Lipid Res (2005) 1.09
Insulin-like growth factor I-mediated skeletal muscle hypertrophy is characterized by increased mTOR-p70S6K signaling without increased Akt phosphorylation. J Investig Med (2005) 1.00
Novel effect of oxidized low-density lipoprotein: cellular ATP depletion via downregulation of glyceraldehyde-3-phosphate dehydrogenase. Circ Res (2006) 0.95
ANG II induces apoptosis of human vascular smooth muscle via extrinsic pathway involving inhibition of Akt phosphorylation and increased FasL expression. Am J Physiol Heart Circ Physiol (2005) 0.88
Different growth properties of neointimal and medial smooth muscle cells in response to growth factors. J Vasc Res (2003) 0.88
Differential requirement for nitric oxide in IGF-1-induced anti-apoptotic, anti-oxidant and anti-atherosclerotic effects. FEBS Lett (2011) 0.87
Neurohormonal factors in the development of catabolic/anabolic imbalance and cachexia. Int J Cardiol (2002) 0.84
Protein chip-based microarray profiling of oxidized low density lipoprotein-treated cells. Proteomics (2005) 0.77